Cases & Deals

Xerys invests in Biolog-id

Clients Xerys SA

Jones Day represented Xerys SA in connection with its purchase of Preferred Stock in a private placement by Biolog-id, a company focused on traceability solutions for health products and processes used for labile blood components.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.